The table below shows HUTCHMED (China) Ltd's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$548.51M
$630.20M
$838.00M
$426.41M
$356.13M
$227.98M
Cost of revenue
$336.35M
$348.88M
$384.45M
$311.10M
-
-
Gross profit
-
-
-
-
-
-
R&D
$148.29M
$212.11M
$302.00M
$386.89M
$299.09M
$174.78M
SG&A
HCM annual revenue (10-K history)
HUTCHMED (China) Ltd reported annual revenue of $548.51M for fiscal year 2025. That is down 13.0% from $630.20M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $216.08M (FY 2016) to $548.51M. Figures come from the company's audited annual reports as filed with the SEC.
